ClinicalTrials.gg
Drug

Tamsulosin clinical trials

Also written Flomax, HIP1402 and Harnal.

studies test it
155
open now
24
in phase 3
36
first study started
1997

How each study uses Tamsulosin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tamsulosin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Apr 1997 · FLOMAX · NDA 020579 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tamsulosin
84
Tamsulosin Hydrochloride
19
Tamsulosin 0.4 mg
7
Tamsulosin HCL
6
Tamsulosin 0.2mg
6

Brand

Flomax
31
Harnal
2

Development codes

HIP1402
3
BR9006-1
1

In one entry with another drug

Given together, or one or the other

tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
2
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)
2
dutasteride/tamsulosin
2

Studies by the year they started

153 studies that test it; most in 2021 (12)

Studies that test Tamsulosin, by start year
YearStudies
19971
19983
19991
20012
20021
20031
20042
20056
20064
20075
20083
20093
20109
20112
20126
20137
201411
201511
20166
20177
20183
20194
20205
202112
20225
20237
20246
20259
202611

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
33
Phase 2
19
Phase 3
36
Phase 4
44
No phase
25

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 58 · Other 97

Boehringer Ingelheim (14) · Mansoura University (8) · GlaxoSmithKline (7) · Ain Shams University (5) · Astellas Pharma Europe B.V. (5) · Hanmi Pharmaceutical Company Limited (5) · Berlin-Chemie AG Menarini Group (3) · Beni-Suef University (3)

Often tested with

Tested in the same studies.

Solifenacin (15) · Tadalafil (9) · Silodosin (7) · Mirabegron (7) · Dutasteride (6) · Finasteride (3) · HCP1303 (2) · HGP1201 (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 11, 3 in phase 3

Studies that test Tamsulosin, phase 3 first.

Studies

Open first, then newest update. How each study uses Tamsulosin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 155

See all 155 studies that test Tamsulosin →

Given beside what is tested · 17 — Tamsulosin is usual care or a partner of the new treatment
As the comparator · 26 — what is tested is compared with Tamsulosin

Showing 20 of 26.

Codes

What other systems call Tamsulosin · ClinicalTrials.gg INT006718

  • MeSH (NLM) D000077409TamsulosinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) G3P28OML5ITAMSULOSINConfirmed FDA, NLM, Wikidata
  • RxNorm 77492Confirmed FDA, Wikidata
  • Wikidata Q418480tamsulosinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C75055TamsulosinOne source FDA
  • DrugBank DB00706One source Wikidata

Also registered as tamsulosin hydrochloride (UNII 11SV1951MR · RxNorm 236495).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.